San Diego's Lumena Pharmaceuticals Files For $75 Million IPO To Fund Liver Drug Trials

Published: Apr 04, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Lumena Pharmaceuticals, a clinical-stage biotech developing candidates for rare liver diseases, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering. The San Diego, CA-based company, which was founded in 2011, plans to list on the NASDAQ under the symbol LIVR. Lumena Pharmaceuticals initially filed confidentially on February 28, 2014. Citi, Cowen & Company and Leerink Partners are the joint bookrunners on the deal. No pricing terms were disclosed.

Help employers find you! Check out all the jobs and post your resume.

Back to news